After 2 years of building in silence we’re so excited to finally share what we’ve been working on at AminoChain and announce our $5M seed round led by @a16zcrypto !

What if protecting a biobank’s privacy also limits what it can learn? Once a sample is fully anonymized, you can’t ask follow-up questions, share relevant findings, or connect it to outcomes years later. Is one-time, fully anonymized biobanking still the gold standard — or a limitation on what biological data can answer? Where do you land?

WES focuses on protein-coding regions. WGS looks across the genome. The right choice depends on the research question. Banking the underlying specimen keeps options open as those questions evolve. That’s the approach we take at AminoChain.

A lot of research samples are collected once, then stored away. At AminoChain, your sample stays connected to a record that can grow with your health story, opening possibilities for future research. One contribution, more than one chance to matter.

Living with Myasthenia Gravis? Join our secure at-home study, earn up to $250, and help advance research! aminochain.io/mg-study #MyastheniaGravis #PatientCenteredResearch #RareDisease #DecentralizedTrials

When muscles fail, life changes. Join AminoChain's patient-centered MG research from home. Your experience matters. #MyastheniaGravis #RareDisease #PatientCenteredResearch #ClinicalResearch #PatientVoices #Biotech #DecentralizedTrials

For many with Myasthenia Gravis, vision and eyelid changes signal early signs. Join @AminoChain's patient-centered study from home to help improve MG care. Lend your experience. #MGResearch #PatientPower

What comes after a diagnosis? On April 9, we are bringing together people living with lupus and myasthenia gravis for a relaxed evening of conversation, connection, and community. No jargon. No pressure. Just real talk about research, what participating actually looks like, and meeting others who get it. Whether you are newly diagnosed, years in, or supporting someone you love, you are welcome. Mountain View • 5:30–7:30 PM Save your spot: luma.com/aglf9b4v

“Data sharing is necessary to truly understand MG, which is ‘continuously elusive’ and has many different faces.” — Anita Longoria, Patient Advocate and founder of m.facebook.com/groups/167899… Help shape the future of MG care from home. @AminoChain, in partnership with @imyoohealth , is launching the Myasthenia Gravis Repository Initiative and recruiting 60 U.S. participants (≈50 with MG, ≈10 comparison) for at home blood collection for whole genome sequencing and longitudinal immune profiling. Built on privacy first technology, this study keeps participants directly connected to their samples and data, provides regular updates, and gives a clear window into how contributions are used. Learn more and join: aminochain.io/mg-study #MyastheniaGravis #MG #PatientCentricResearch #MolecularTools #RareDisease

Finding biosamples shouldn’t feel like hide and seek🧬 The @Amino_Chain Specimen Center connects researchers to a global network of biobanks making it easier to find exactly what you need, when you need it.

Three years ago, we started with a bold idea to create a decentralized marketplace for bio samples. Today, that network spans more than 25 institutions worldwide, connecting leading medical centers and researchers. Now we are taking it further. The next phase of the AminoChain protocol brings us back to our original vision: giving patient donors control and visibility from the very beginning. Through a simple kit and secure app, patients can see where their samples go, how their data is used, and even share in the value created from research outcomes. It is the next step toward a connected research ecosystem where everyone benefits: patient donors, researchers, and innovation itself. #PatientCentricResearch #AminoChain #UXforScience

Sometimes you know exactly what you’re looking for and sometimes you need to explore. Enhanced Search adapts to both. You can start broad (“cancer”) and refine step by step, or switch to filters for complete control. Either way, you get results that make sense, fast. Enhanced Search is now live in the Specimen Center → app.aminochain.io

What if medical data could move safely, transparently, and reward everyone involved? That is the future AminoChain is building. A blockchain‑powered infrastructure that connects patients, researchers, and sponsors in a single, privacy‑first ecosystem, authenticating contributions, tracking where samples and data go, and ensuring fair value sharing for all. From AI training to clinical trial recruitment, our protocol makes innovation possible without exposing personal information. Every contribution fuels discovery and every discovery gives back.

At age 12, @casparbarnes123 donated a biopsy for cancer research. He never learned what happened to it. Now he’s building @Amino_Chain on the Syndicate Network—a decentralized biobank where patients can track samples, control their data, and share in discoveries they enable.

The @GeneticsSociety 2025 annual conference did not disappoint. Amazing science, great people, and inspiring about the future of genetics and medicine. #ASHG2025 #PatientCentricResearch #AminoChain

AminoChain is dedicated to building a system where biomedical science is accelerated without leaving the people who power it behind! If this resonates with you, be sure to tune in to @casparbarnes123 on this spaces. See you there!

The networks of tomorrow are here. Tomorrow at 1pm ET, we’re hosting an X Space with @casparbarnes123 @sirsuhayb of @Amino_Chain @stadium_gg. They'll share what they’re building, why they launched their own chain, and what’s next. Set a reminder ↓ nitter.net/i/spaces/1OwxWeborAQGQ

The AminoChain team is heading to @GeneticsSociety Annual Meeting 2025 in Boston! If you’re attending and would like to connect to chat about patient advocacy, biobanking, data sharing, or what we’re building at AminoChain, we’d love to meet you there. Reach out to @casparbarnes123, @JelaniC3 or stop us at the conference, we’re always happy to talk science, samples, and collaboration. #ASHG2025 #Genomics #Biobanking #DataSharing #AminoChain

📢AminoChain Partner Spotlight📢: Medical Gate Bioscience Founded in 2015, Medical Gate sources and delivers high-quality biospecimens accompanied by comprehensive clinical data and pathology reports, helping the life sciences community advance the prevention, diagnosis, and treatment of diseases. Their collections span a wide range of materials, including: Blood and derivatives - fresh and frozen blood, serum, plasma, and other biofluids Tissues - FFPE, fresh, and frozen tissue samples Covering major disease targets in oncology, autoimmune and metabolic disorders, neurology, kidney diseases, pulmonology, infectious diseases, OB/GYN, and more, their 3,796 unique donors and 18,092 specimens provide researchers with ethically sourced, clinically annotated materials that enable precision studies and translational research. 👉 Explore Medical Gate’s collections now on the Specimen Center: app.aminochain.io Are you a biobank or clinical site looking to amplify your reach and support cutting-edge research? Join the growing network of providers building the future of biospecimen access by visiting us at aminochain.io